Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
It was great to see the Rock Star 2nd cohort are still going after 64 weeks with PSA's still below 1.
would have been nice to have more info on the financing but we will find out soon enough.
tada